Ackerman samuel k - direct investment history in Panacos pharmaceuticals inc

Filed on 2006-05-08 by Ackerman Samuel K SEC CIK 1212145 Form 4

Accession 0001181431-06-028465.txt Sec File: edgar/data/1212145/0001181431-06-028465-index.htm

2006-05-05 Ackerman Samuel K (CIK 1212145) through Direct (President Ceo)

Invested in Panacos Pharmaceuticals Inc bought 10000 shares at $5.62 remaining shares owned 56866

Common Stock Panacos Pharmaceuticals Inc Panc Transaction code: P Open market or private purchase of securities


Filed on 2006-05-08 by Ackerman Samuel K SEC CIK 1212145 Form 4

Accession 0001181431-06-028465.txt Sec File: edgar/data/1212145/0001181431-06-028465-index.htm

2006-05-05 Ackerman Samuel K (CIK 1212145) through Direct (President Ceo)

Invested in Panacos Pharmaceuticals Inc remaining shares owned 1471

Common Stock Panacos Pharmaceuticals Inc Panc

f1 dr. ackerman may be considered the beneficial owner, as the securities are owned by his dependents


Filed on 2006-01-26 by Ackerman Samuel K SEC CIK 1212145 Form 4

Accession 0001181431-06-005850.txt Sec File: edgar/data/1212145/0001181431-06-005850-index.htm

2006-01-24 Ackerman Samuel K (CIK 1212145) through Direct (President Ceo)

Invested in Panacos Pharmaceuticals Inc bought 860000 shares at $0 remaining shares owned 860000

Stock Option Right To Buy Panacos Pharmaceuticals Inc Panc exercise date 2006-02-24 exercise price 8.27 has valueitem expiration due date 2016-01-24 underlying security shares 860000 underlying security title Common Stock

f1 options to purchase shares of panacos stock will vest monthly in 48 equal installments beginning on february 24, 2006. stock option was granted under the 2005 supplemental equity compensation plan.


Filed on 2005-08-29 by Ackerman Samuel K SEC CIK 1212145 Form 4

Accession 0001181431-05-049259.txt Sec File: edgar/data/1212145/0001181431-05-049259-index.htm

2005-08-25 Ackerman Samuel K (CIK 1212145) through Direct (President Ceo)

Invested in Panacos Pharmaceuticals Inc bought 478 shares at $0 remaining shares owned 48338

Common Stock Panacos Pharmaceuticals Inc Panc Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f3 the ampersand 1999 companion fund limited partnership made a partnership distribution on august 25, 2005. the reporting person received 478 shares of panacos common stock as part of that distribution.
f4 consists of 46,867 shares of common stock owned directly by dr. ackerman and 1,471 shares of common stock of which dr. ackerman may be considered the beneficial owner, as the securities are owned by his dependents.


Filed on 2005-08-29 by Ackerman Samuel K SEC CIK 1212145 Form 4

Accession 0001181431-05-049259.txt Sec File: edgar/data/1212145/0001181431-05-049259-index.htm

2005-08-25 Ackerman Samuel K (CIK 1212145) through Direct (President Ceo)

Invested in Panacos Pharmaceuticals Inc bought 2092 shares at $0 remaining shares owned 47860

Common Stock Panacos Pharmaceuticals Inc Panc Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 the ampersand 1999 companion fund limited partnership made a partnership distribution on august 25, 2005. the reporting person received 2,092 shares of panacos common stock as part of that distribution.
f2 consists of 46,386 shares of common stock owned directly by dr. ackerman and 1,471 shares of common stock of which dr. ackerman may be considered the beneficial owner, as the securities are owned by his dependents.